Kabeer Aziz

CIK: 0001914847

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)12 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANTX

AN2 Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (14 total)

ANTX
AN2 Therapeutics, Inc.
Oct 12, 2026
Award(A)
Direct
2.5K shares-
ANTX
AN2 Therapeutics, Inc.
Jul 10, 2026
Award(A)
Direct
2.9K shares-
ANTX
AN2 Therapeutics, Inc.
Apr 10, 2026
Award(A)
Direct
3.8K shares-
ANTX
AN2 Therapeutics, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (right to buy)
Direct
20.7K shares-
ANTX
AN2 Therapeutics, Inc.
Mar 19, 2026
Award(A)
Stock Option (right to buy)
Direct
20.7K shares-
ANTX
AN2 Therapeutics, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (right to buy)
Direct
23.7K shares-
ANTX
AN2 Therapeutics, Inc.
Mar 19, 2026
Award(A)
Stock Option (right to buy)
Direct
23.7K shares-
ANTX
AN2 Therapeutics, Inc.
Feb 20, 2026
Award(A)
Stock Option (Right to Buy)
Direct
20.4K shares-
ANTX
AN2 Therapeutics, Inc.
Jan 12, 2026
Award(A)
Direct
11.6K shares-
ANTX
AN2 Therapeutics, Inc.
Oct 10, 2025
Award(A)
Direct
10.4K shares-
ANTX
AN2 Therapeutics, Inc.
Jul 10, 2025
Award(A)
Direct
11.9K shares-
ANTX
AN2 Therapeutics, Inc.
May 22, 2025
Award(A)
Stock Optin (Right to Buy)
Direct
19.1K shares-
ANTX
AN2 Therapeutics, Inc.
Apr 10, 2025
Award(A)
Direct
9.7K shares-
ANTX
AN2 Therapeutics, Inc.
Dec 19, 2024
Award(A)
Direct
9K shares-

		Type	Shares	Price		Ownership
Oct 12, 2026	ANTX AN2 Therapeutics, Inc.	Award(A)	2,465	-	$0	Direct
Jul 10, 2026	ANTX AN2 Therapeutics, Inc.	Award(A)	2,852	-	$0	Direct
Apr 10, 2026	ANTX AN2 Therapeutics, Inc.	Award(A)	3,775	-	$0	Direct
Mar 19, 2026	ANTX AN2 Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	20,724	-	-	Direct
Mar 19, 2026	ANTX AN2 Therapeutics, Inc.	Award(A) Stock Option (right to buy)	20,724	-	-	Direct
Mar 19, 2026	ANTX AN2 Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	23,742	-	-	Direct
Mar 19, 2026	ANTX AN2 Therapeutics, Inc.	Award(A) Stock Option (right to buy)	23,742	-	-	Direct
Feb 20, 2026	ANTX AN2 Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	20,400	-	-	Direct
Jan 12, 2026	ANTX AN2 Therapeutics, Inc.	Award(A)	11,560	-	$0	Direct
Oct 10, 2025	ANTX AN2 Therapeutics, Inc.	Award(A)	10,367	-	-	Direct
Jul 10, 2025	ANTX AN2 Therapeutics, Inc.	Award(A)	11,875	-	-	Direct
May 22, 2025	ANTX AN2 Therapeutics, Inc.	Award(A) Stock Optin (Right to Buy)	19,111	-	-	Direct
Apr 10, 2025	ANTX AN2 Therapeutics, Inc.	Award(A)	9,705	-	-	Direct
Dec 19, 2024	ANTX AN2 Therapeutics, Inc.	Award(A)	8,972	-	$0	Direct

1-14 of 14 transactions

About Aziz Kabeer

Aziz Kabeer (SEC CIK 0001914847) files insider reports with the SEC as Director of AN2 Therapeutics, Inc. (ANTX).

Signal8 holds 11 ownership filings by Aziz Kabeer, all Form 4s, filed between Dec 23, 2024 and Oct 13, 2026. Those filings report 14 transactions, from Dec 19, 2024 to Oct 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Aziz Kabeer's filings is in MENLO PARK, CA.

Recent filings by Aziz Kabeer

Oct 12, 2026: Grant or award of ANTX shares (Form 4, code A).
Jul 10, 2026: Grant or award of ANTX shares (Form 4, code A).
Apr 10, 2026: Grant or award of ANTX shares (Form 4, code A).
Mar 19, 2026: Disposition to issuer transaction of ANTX derivative securities (Form 4, code D).
Mar 19, 2026: Grant or award of ANTX derivative securities (Form 4, code A).

Other insiders filing for AN2 Therapeutics, Inc. (ANTX)

Marks Gilbert Lynn, Director
Martin Patricia A., Director
Trenor Cameron C. III, Chief Medical Officer
Readnour Robin Shane, Director
Williams Sarah Joanne, Principal Accounting Officer
FitzPatrick Margaret M, Director

How to read Form 4 transaction codes